Zeto, Inc. develops wearable EEG devices and an AI-driven cloud platform for brain monitoring and diagnostics. Its systems enable monitoring across ICUs, emergency departments, hospitals, offices and the home, and the company provides nationwide monitoring and interpretation services by neurologists. Zeto's platform offers AI-driven notifications for seizures and epilepsy, and its EEG systems received FDA clearances in 2018 and 2024; the systems are commercially available in the United States. The company plans to expand capabilities to detect and manage conditions including depression, stroke and traumatic brain injury. Zeto reports rapid adoption by leading U.S. healthcare institutions and says the new funding will support expansion of commercial and operational teams and strengthen research and development. The company is headquartered in Santa Clara, Calif.

Total raised

$31M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2025